Wall Street’s Evan David Seigerman stirred the pot by slashing his price target on Eli Lilly stock—but not his enthusiasm.

First Trust Advisors LP beefed up its stake in Home Depot by snagging nearly 32,000 more shares, now owning 680,703 in total.

Procter & Gamble saw a significant shakeup in shareholder activity, especially as Ossiam slashed its holdings by more than ...

Tower Research Capital gave Johnson & Johnson’s portfolio a serious vitamin boost, increasing its stake by 71.4% in Q4. The ...

Natixis has significantly reduced its investment in Bank of America, trimming its stake by nearly 23% in the fourth quarter.

Berkshire Hathaway B is gaining investor attention, despite a recent dip in its stock performance. Over the past month, ...

Tesla teased investors with a promise of a new low-cost model by mid-2025, sparking initial excitement—until details emerged.

AbbVie is set to report earnings on April 25, with revenue expected to top $13.17 billion and EPS hitting $2.44. Insiders at ...

First Trust Advisors LP expanded its Walmart holdings by 238,714 shares, now totaling just under 3 million shares valued at ...

Representative Robert Bresnahan, Jr. of Pennsylvania recently ditched some Meta Platforms shares, selling between $1,001 and ...

Morgan Stanley just slapped a cold compress on UnitedHealth Group, trimming its price target from $664 to $563 while still ...

Ossiam offloaded nearly half of its JPMorgan Chase holdings in Q4, selling 33,181 shares and trimming its position to 33,666 ...